|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,596,522 |
|
|
Indirect Value
|
$12,923,651,413 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,005,247,936 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 30 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2008-03-14 |
4 |
B |
$8.06 |
$2,665 |
I/I |
330 |
477,052 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-14 |
4 |
B |
$8.06 |
$373,899 |
I/I |
46,306 |
3,933,090 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-14 |
4 |
B |
$8.67 |
$147 |
I/I |
17 |
74,977 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-14 |
4 |
B |
$8.67 |
$30,642 |
I/I |
3,536 |
5,006,172 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-14 |
4 |
B |
$8.67 |
$11,491 |
I/I |
1,326 |
2,202,321 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-14 |
4 |
B |
$8.67 |
$78 |
I/I |
9 |
144,112 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-14 |
4 |
B |
$8.67 |
$971 |
I/I |
112 |
129,393 |
1.42 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-14 |
4 |
B |
$8.06 |
$997,429 |
I/I |
123,528 |
7,813,945 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-17 |
4 |
B |
$8.14 |
$46,464 |
I/I |
5,711 |
5,011,883 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-17 |
4 |
B |
$7.80 |
$551,968 |
I/I |
70,757 |
7,884,702 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-17 |
4 |
B |
$7.80 |
$17,513 |
I/I |
2,245 |
155,230 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-17 |
4 |
B |
$7.80 |
$1,474 |
I/I |
189 |
477,241 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-17 |
4 |
B |
$7.80 |
$186,231 |
I/I |
23,873 |
3,956,963 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-17 |
4 |
B |
$8.14 |
$15,678 |
I/I |
1,927 |
2,204,248 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-17 |
4 |
B |
$8.14 |
$122 |
I/I |
15 |
144,127 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-03-17 |
4 |
B |
$8.14 |
$1,473 |
I/I |
181 |
129,574 |
1.42 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-18 |
4 |
B |
$8.02 |
$423,038 |
I/I |
52,736 |
7,937,438 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-18 |
4 |
B |
$8.02 |
$13,420 |
I/I |
1,673 |
156,903 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-18 |
4 |
B |
$8.02 |
$1,131 |
I/I |
141 |
477,382 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-18 |
4 |
B |
$8.02 |
$142,732 |
I/I |
17,793 |
3,974,756 |
2.25 |
- |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2008-04-03 |
4 |
S |
$0.11 |
$2,557 |
I/I |
(23,056) |
1,821,429 |
0 |
- |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2008-04-03 |
4 |
S |
$0.11 |
$58 |
I/I |
(521) |
41,120 |
0 |
- |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2008-04-03 |
4 |
S |
$0.11 |
$158 |
I/I |
(1,423) |
112,451 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-04-04 |
4 |
B |
$13.28 |
$1,011,152 |
I/I |
76,141 |
1,156,516 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-04-04 |
4 |
B |
$13.28 |
$131,963 |
I/I |
9,937 |
53,045 |
1.5 |
- |
|
1397 Records found
|
|
Page 30 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|